NT5E and neoplasm: While CD73 inhibitors can stimulate anti-tumor immunity, early studies reported that targeting CD73 can also inhibit human tumor xenografts in severely immunocompromised mice (Zhou et al., 2007; Zhi et al., 2007; Zhi et al., 2010; Rust et al., 2013).